Breaking News Instant updates and real-time market news.

PCRX

Pacira

$36.10

0.2 (0.56%)

15:37
02/15/18
02/15
15:37
02/15/18
15:37

Pacira 'confident' data supports Exparel label expansion despite 4-6 panel vote

Pacira Pharmaceuticals announced that the U.S. Food and Drug Administration's Anesthetic and Analgesic Drug Products Advisory Committee did not reach a unanimous decision on the efficacy and safety of the use of Exparel as a nerve block to produce regional analgesia. The committee's feedback will be considered by the FDA in its review of the company's sNDA seeking expansion of the Exparel label. The Prescription Drug User Fee Act, or PDUFA, date for completion of the review is April 6, 2018. Four committee members voted to recommend FDA approval of the Exparel sNDA while six believed that more research is needed to further support the proposed new indication. "We remain confident that the data from our clinical program provides all of the necessary information to support expansion of the current Exparel label for infiltration to also include use as a nerve block for regional analgesia. We look forward to working with the FDA to address any outstanding questions as we move through the sNDA review process toward our ultimate goal of offering additional flexibility in the way Exparel can be administered so that clinicians and patients alike have increased opportunity to realize the benefits of long-lasting non-opioid pain control," said Dave Stack, chairman and CEO at Pacira.

  • 15

    Feb

  • 21

    Feb

  • 06

    Apr

PCRX Pacira
$36.10

0.2 (0.56%)

02/13/18
PIPR
02/13/18
NO CHANGE
Target $49
PIPR
Overweight
Pacira briefing materials 'clearly a mixed bag,' says Piper Jaffray
Briefing materials for the upcoming meeting of the FDA's Anesthetic and Analgesic Drug Products Advisory Committee to discuss Pacira Pharmaceuticals' filing for Exparel administration via upper and lower extremity nerve block were "clearly a mixed bag," Piper Jaffray analyst David Amsellem tells investors in a research note. He believes this is not a surprise since the results of the studies supporting the filing were a "mixed bag." The analyst's read of the documents suggests that a label expansion in femoral nerve block is "likely off the table." That said, the documents did not focus significantly on the successful upper extremity study, and the voting questions clearly leave open the possibility of a narrow label expansion, Amsellem contends. He reiterates an Overweight rating on Pacira with a $49 price target.
02/12/18
BMOC
02/12/18
NO CHANGE
BMOC
Market Perform
BMO says Pacira briefing docs reveal 'several uncertainties' for Exparel
BMO Capital analyst Gary Nachman said his quick review of the FDA's analysis and draft questions for the upcoming advisory committee meeting reveal "several uncertainties" about Exparel in terms of consistency across studies and how the drug compares with IR bupivacaine. On efficacy, the FDA "appears to be cautious" about providing a broad label for nerve block, said Nachman, who keeps a Market Perform rating on Pacira shares.
02/07/18
PIPR
02/07/18
NO CHANGE
Target $49
PIPR
Overweight
Piper 'cautiously optimistic' into Pacira FDA advisory panel
Piper Jaffray analyst David Amsellem remains "cautiously optimistic" on a favorable outcome into the FDA's Anesthetic and Analgesic Drug Products Advisory Committee meeting on February 14 and 15 to discuss Pacira Pharmaceuticals' supplemental new drug application filing for Exparel administration via upper and lower extremity nerve block. The analyst continues to believe that Exparel, even without a label expansion, is well positioned for "significant and sustainable" growth. He reiterates an Overweight rating on Pacira with a $49 price target.
01/19/18
GHSC
01/19/18
INITIATION
Target $51
GHSC
Buy
Pacira initiated with a Buy at Seaport Global
Seaport Global analyst Corey David initiated Pacira with a Buy and $51 price target. The analyst believes Exparel growth rates have bottomed and will begin to reaccelerate in 2018.

TODAY'S FREE FLY STORIES

PLNT

Planet Fitness

$66.76

-0.825 (-1.22%)

18:44
03/22/19
03/22
18:44
03/22/19
18:44
Hot Stocks
Planet Fitness CEO: We have a streamlined business model »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRDM

Iridium

$26.40

-0.38 (-1.42%)

18:22
03/22/19
03/22
18:22
03/22/19
18:22
Hot Stocks
Iridium CEO: We've doubled our bottom line over the past eight years »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

, SPX

S&P 500

$0.00

(0.00%)

18:05
03/22/19
03/22
18:05
03/22/19
18:05
General news
Sen. Sanders calls on White House to make Mueller report public »

U.S. Senator and…

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$279.37

-5.26 (-1.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IDTI

Integrated Device

$47.80

-0.04 (-0.08%)

, RNECY

Renesas

$0.00

(0.00%)

18:02
03/22/19
03/22
18:02
03/22/19
18:02
Hot Stocks
Integrated Device, Renesas receive final approval for merger »

Renesas Electronics…

IDTI

Integrated Device

$47.80

-0.04 (-0.08%)

RNECY

Renesas

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

, SPX

S&P 500

$0.00

(0.00%)

17:48
03/22/19
03/22
17:48
03/22/19
17:48
General news
Senator Warren urges AG Barr to release Mueller report to the public »

U.S. Senator and…

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$279.37

-5.26 (-1.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$362.49

-10.2 (-2.74%)

17:44
03/22/19
03/22
17:44
03/22/19
17:44
Hot Stocks
Lawmaker urges FAA, Boeing workers to utilize whistleblower page »

Chair of the House…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

GLD

SPDR Gold Shares

$123.97

0.29 (0.23%)

17:44
03/22/19
03/22
17:44
03/22/19
17:44
Hot Stocks
SPDR Gold Shares holdings rise to 781.03MT from 778.09MT »

This is the highest level…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

17:40
03/22/19
03/22
17:40
03/22/19
17:40
General news
Weekly CFTC Commitment of Traders highlights »

10-YEAR U.S. TREASURY net…

ONEXF

Onex

$0.00

(0.00%)

17:35
03/22/19
03/22
17:35
03/22/19
17:35
Hot Stocks
Onex to acquire Gluskin Sheff »

Onex Corporation and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DZSI

DASAN Zhone

$12.10

-0.12 (-0.98%)

17:35
03/22/19
03/22
17:35
03/22/19
17:35
Syndicate
Breaking Syndicate news story on DASAN Zhone »

DASAN Zhone files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

REPH

Recro Pharma

$9.73

0.1 (1.04%)

17:35
03/22/19
03/22
17:35
03/22/19
17:35
Hot Stocks
Breaking Hot Stocks news story on Recro Pharma »

Recro Pharma trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Mar

DZSI

DASAN Zhone

$12.10

-0.12 (-0.98%)

17:35
03/22/19
03/22
17:35
03/22/19
17:35
Syndicate
Breaking Syndicate news story on DASAN Zhone »

DASAN Zhone files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

, SPX

S&P 500

$0.00

(0.00%)

17:34
03/22/19
03/22
17:34
03/22/19
17:34
General news
White House says hasn't received, been briefed on Mueller report, WSJ says »

Following confirmation…

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$279.37

-5.26 (-1.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CATS

Catasys

$13.19

-0.39 (-2.87%)

17:26
03/22/19
03/22
17:26
03/22/19
17:26
Syndicate
Breaking Syndicate news story on Catasys »

Catasys files $50M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USWS

U.S. Well Services

$7.74

-0.54 (-6.52%)

17:20
03/22/19
03/22
17:20
03/22/19
17:20
Syndicate
Breaking Syndicate news story on U.S. Well Services »

U.S. Well Services files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADIL

Adial Pharmaceuticals

$2.97

-0.12 (-3.88%)

17:17
03/22/19
03/22
17:17
03/22/19
17:17
Syndicate
Breaking Syndicate news story on Adial Pharmaceuticals »

Adial Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STNG

Scorpio Tankers

$18.85

-0.66 (-3.38%)

17:16
03/22/19
03/22
17:16
03/22/19
17:16
Syndicate
Breaking Syndicate news story on Scorpio Tankers »

Scorpio Tankers files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NAVB

Navidea

$0.14

-0.0001 (-0.07%)

17:13
03/22/19
03/22
17:13
03/22/19
17:13
Syndicate
Navidea offers to sell $3M in common stock for existing shareholder »

Navidea…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

, SPX

S&P 500

$0.00

(0.00%)

17:11
03/22/19
03/22
17:11
03/22/19
17:11
General news
Mueller delivers Russia report to AG William Barr, CNBC reports »

Special counsel Robert…

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$279.37

-5.26 (-1.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$362.49

-10.2 (-2.74%)

, NOC

Northrop Grumman

$268.29

-4.01 (-1.47%)

17:10
03/22/19
03/22
17:10
03/22/19
17:10
Hot Stocks
Boeing awarded $4.14B Missle Defense Agency contract »

Boeing (BA) has been…

BA

Boeing

$362.49

-10.2 (-2.74%)

NOC

Northrop Grumman

$268.29

-4.01 (-1.47%)

RTN

Raytheon

$179.98

-1.94 (-1.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

AAPL

Apple

$190.97

-4.1 (-2.10%)

17:09
03/22/19
03/22
17:09
03/22/19
17:09
Periodicals
Partners not sure how Apple plans to package, price video service, CNBC says »

Apple is set to announce…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

RIVE

Riverview Financial

$11.20

(0.00%)

17:05
03/22/19
03/22
17:05
03/22/19
17:05
Syndicate
Breaking Syndicate news story on Riverview Financial »

Riverview Financial files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIVE

Riverview Financial

$11.20

(0.00%)

17:05
03/22/19
03/22
17:05
03/22/19
17:05
Syndicate
Breaking Syndicate news story on Riverview Financial »

Riverview Financial files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EOLS

Evolus

$24.02

-1.66 (-6.46%)

17:01
03/22/19
03/22
17:01
03/22/19
17:01
Syndicate
Breaking Syndicate news story on Evolus »

Evolus files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EOLS

Evolus

$24.02

-1.66 (-6.46%)

17:00
03/22/19
03/22
17:00
03/22/19
17:00
Syndicate
Breaking Syndicate news story on Evolus »

Evolus files $250M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.